Search Results (189)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA. | Academic Article |
Why?
|
| Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. | Academic Article |
Why?
|
| A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis. | Academic Article |
Why?
|
| Association of differentially expressed genes and autoantibody type in patients with systemic sclerosis. | Academic Article |
Why?
|
| Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis. | Academic Article |
Why?
|
| Cyclophosphamide in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. | Academic Article |
Why?
|
| Distinct gene network in skin lesion of patients with diffuse cutaneous systemic sclerosis. | Academic Article |
Why?
|
| FocuSSced on the Target in Systemic Sclerosis-Interstitial Lung Disease: Another Arrow in the Quiver? | Academic Article |
Why?
|
| Glucocorticoids in systemic sclerosis: patients' beliefs and treatment adherence. | Academic Article |
Why?
|
| Guidance for stem cell therapy for juvenile systemic sclerosis patients. | Academic Article |
Why?
|
| High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. | Academic Article |
Why?
|
| Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis. | Academic Article |
Why?
|
| Machine-learning classification identifies patients with early systemic sclerosis as abatacept responders via CD28 pathway modulation. | Academic Article |
Why?
|
| Mycophenolate in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. | Academic Article |
Why?
|
| Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures. | Academic Article |
Why?
|